Fighting the Health Challenges of Diabetes in Hong Kong: A Window Into Mainland China.
作者信息
Lee Paul C H, Woo Y C, Lam Karen S L
机构信息
All of the authors are with the Department of Medicine, University of Hong Kong, Hong Kong SAR, China.
出版信息
Am J Public Health. 2018 Dec;108(12):1623-1624. doi: 10.2105/AJPH.2018.304740.
Abstract
摘要
相似文献
1
Fighting the Health Challenges of Diabetes in Hong Kong: A Window Into Mainland China.
Am J Public Health. 2018 Dec;108(12):1623-1624. doi: 10.2105/AJPH.2018.304740.
2
Back to the future--do IGT and IFG have value as clinical entities?
Diabetes Res Clin Pract. 2008 Aug;81(2):131-3. doi: 10.1016/j.diabres.2008.07.001.
3
Rapid increase in the prevalence of undiagnosed diabetes and impaired fasting glucose in asymptomatic Hong Kong Chinese.
Diabetes Care. 1999 Oct;22(10):1751-2. doi: 10.2337/diacare.22.10.1751.
4
The prevalence of diabetes mellitus and impaired glucose tolerance among Hong Kong Chinese adults of working age.
Diabetes Res Clin Pract. 1993 Jul;21(1):67-73. doi: 10.1016/0168-8227(93)90099-q.
5
Use of the 1997 American Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population.
Diabetes Care. 1998 Dec;21(12):2094-7. doi: 10.2337/diacare.21.12.2094.
6
Development and validation of a diabetes mellitus and prediabetes risk prediction function for case finding in primary care in Hong Kong: a cross-sectional study and a prospective study protocol paper.
BMJ Open. 2022 May 24;12(5):e059430. doi: 10.1136/bmjopen-2021-059430.
7
Glucose intolerance, metabolic syndrome, and neuropathy.
Handb Clin Neurol. 2014;126:109-22. doi: 10.1016/B978-0-444-53480-4.00009-6.
8
External validation of the Hong Kong Chinese non-laboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care.
J Diabetes Investig. 2024 Sep;15(9):1317-1325. doi: 10.1111/jdi.14256. Epub 2024 Jun 21.
9
[The preventive value of supplementary diabetes screening by the detection of cases of latent diabetes mellitus].
Wien Med Wochenschr. 1971 Jun 19;121(25):525-7.
10
Transplant-associated hyperglycemia: shedding light on the mechanisms.
Clin J Am Soc Nephrol. 2010 Apr;5(4):560-2. doi: 10.2215/CJN.01430210. Epub 2010 Mar 25.
本文引用的文献
1
The primary health-care system in China.
Lancet. 2017 Dec 9;390(10112):2584-2594. doi: 10.1016/S0140-6736(17)33109-4. Epub 2017 Dec 8.
2
Validation of the diabetes screening tools proposed by the American Diabetes Association in an aging Chinese population.
PLoS One. 2017 Sep 14;12(9):e0184840. doi: 10.1371/journal.pone.0184840. eCollection 2017.
3
Declining Trends of Cardiovascular-Renal Complications and Mortality in Type 2 Diabetes: The Hong Kong Diabetes Database.
Diabetes Care. 2017 Jul;40(7):928-935. doi: 10.2337/dc16-2354. Epub 2017 May 10.
4
Cardiometabolic risk profile of participants with prediabetes diagnosed by HbA1c criteria in an urban Hong Kong Chinese population over 40 years of age.
Diabet Med. 2015 Sep;32(9):1207-11. doi: 10.1111/dme.12691. Epub 2015 Feb 6.
5
Prevalence and control of diabetes in Chinese adults.
JAMA. 2013 Sep 4;310(9):948-59. doi: 10.1001/jama.2013.168118.
6
Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study.
Diabetes Care. 2007 Jun;30(6):1430-6. doi: 10.2337/dc06-1820. Epub 2007 Mar 2.
7
The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Chinese. Hong Kong Cardiovascular Risk Factor Steering Committee. American Diabetes Association.
Diabet Med. 2000 Oct;17(10):741-5. doi: 10.1046/j.1464-5491.2000.00376.x.
Zotero 插件